Burgess, Melissa A.
University of Pittsburgh
4 papers on CoChatORCID 0000-0002-5753-1422
Most cited papers
- Verified
B cells are associated with survival and immunotherapy response in sarcoma
Petitprez, F., de Reyniès, A., Keung, E. Z., Chen, T. W.-W., Sun, C.-M., Calderaro, J., Jeng, Y.-M., Hsiao, L.-P., Lacroix, L., Bougoüin, A., et al. (2020) · Nature
Sarcoma Diagnosis and TreatmentCancer Immunotherapy and Biomarkers
Cited by 1,942
- Verified
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial
Tawbi, H. A., Burgess, M., Bolejack, V., Van Tine, B. A., Schuetze, S. M., Hu, J., D'Angelo, S., Attia, S., Riedel, R. F., Priebat, D. A., et al. (2017) · The Lancet Oncology
Sarcoma Diagnosis and TreatmentCancer Immunotherapy and Biomarkers
Cited by 1,452
- Verified
Durable tumor regression and overall survival in patients with advanced Merkel cell carcinoma receiving pembrolizumab as first-line therapy
Nghiem, P., Bhatia, S., Lipson, E. J., Sharfman, W. H., Kudchadkar, R. R., Brohl, A. S., Friedlander, P. A., Daud, A., Kluger, H. M., Reddy, S. A., et al. (2019) · Journal of Clinical Oncology
Polyomavirus and related diseasesNonmelanoma Skin Cancer Studies
Cited by 396
- Verified
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab
Keung, E. Z., Burgess, M., Salazar, R., Parra, E. R., Rodrigues-Canales, J., Bolejack, V., Van Tine, B. A., Schuetze, S. M., Attia, S., Riedel, R. F., et al. (2020) · Clinical Cancer Research
Cancer Immunotherapy and BiomarkersSarcoma Diagnosis and Treatment
Cited by 215
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free